Home > Browse Research > Life Sciences > Biotechnology > Stem Cell

Stem Cell: market research reports

Stem cells are unique in that they are undifferentiated cells that can differentiate to become virtually any type of cell in the body (totipotent). They therefore represent an ongoing source of the specialized cells that make up the tissues and organs. There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies.

Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells.

Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.

Stem Cell market research reports and industry analysis

Mesenchymal Stem Cells - Advances and Applications 6/1/2013 \| published by: BioInformant Worldwide, L.L.C. ... intense therapeutic interest because they represent a population of cells with the potential to treat a wide range of acute and degenerative diseases. MSCs are advantageous over other stem cells types for a variety of ... \| read more...	$3,495.00
Global Gene Therapy Market Analysis 6/1/2013 \| published by: RNCOS ... the most sought after research objectives for ‘difficult to cure’ diseases. The gene therapy market in spite of presenting few marketable products and being nascent in terms of revenue generation holds tremendous growth potential. As ... \| read more...	$1,200.00
Complete 2012-13 Induced Pluripotent Stem Cell Industry Report 6/1/2013 \| published by: BioInformant Worldwide, L.L.C. ... them to differentiate into a wide variety of specialized cell types. The possibilities arising from these characteristics has caused great commercial interest, with potential applications ranging from the use of stem cells in reversal or ... \| read more...	$3,495.00
Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products 5/23/2013 \| published by: Kalorama Information ... as a result of aging populations in the U.S., Europe and Japan; ongoing technology advancements/new product introductions and indications; expansion of health coverage in the U.S. via health care reform; and continued strong promotion of ... \| read more...	$3,500.00
Cancer Stem Cells Drug Pipeline Update 2013 4/22/2013 \| published by: BioSeeker Group AB ... development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today ... \| read more...	$5,621.25
Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version) 4/1/2013 \| published by: BioInformant Worldwide, L.L.C. ... blood banks exist in nearly every developed country, as well as within several developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry, over only a seven year period. This ... \| read more...	$3,995.00
Advances in Gene Therapy 3/25/2013 \| published by: Datamonitor ... market outlook for the use of gene therapies in the treatment of rare monogenic diseases and common polygenic diseases. The potential threat to the protein therapy market is also assessed. Features and benefits Compares the ... \| read more...	$3,500.00
Hematopoietic Stem Cell Transplantation – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... the therapeutic development for Hematopoietic Stem Cell Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hematopoietic Stem Cell Transplantation. ... \| read more...	$2,000.00
Cellular Therapy and Cord Blood 2013 Market Report 2/1/2013 \| published by: Select Biosciences Limited ... order to characterize the growth and evolution of the cellular therapy field--in this vein, we present primary industry data that Select Biosciences has collected as part of its continual industry tracking of this space. We've ... \| read more...	$2,185.00
Regenerative medicine and Stem cells Partnering Terms and Agreements 2/1/2013 \| published by: Current Partnering ... companies. Trends in regenerative medicine and stem cells deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for regenerative medicine and stem cells The ... \| read more...	$2,695.00
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2013 1/1/2013 \| published by: Select Biosciences Limited ... as they are fast evolving. CTCs have been shown to have prognostic value in a number of cancer types and therefore there is extensive research and development activity to develop methodologies for CTC enumeration as ... \| read more...	$2,125.00
Perspective: From Promise to Practice — Translational Medicine at the Consumer Doorstep 12/16/2012 \| published by: IDC ... today and over the near future. The life science and healthcare ecosystems are increasingly interconnected, which promises to more rapidly and effectively translate discoveries into actionable information for all involved. This new approach is supported ... \| read more...	$1,500.00
Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity 12/14/2012 \| published by: GBI Research ... Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity”. The report provides an in-depth analysis on stem cell research and development in India, China, ... \| read more...	$3,500.00
Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017) 12/1/2012 \| published by: Daedal Research ... reach increases, regulatory approvals grow for stem cell based products and the resistance to private banks declines. Over 170 different cord blood banking service providers are offering services in different regions of the world. This ... \| read more...	$700.00
Stem Cell Research Products: Opportunities, Tools, & Technologies 12/1/2012 \| published by: BioInformant Worldwide, L.L.C. ... report for the stem cell research supply market. Whether you already supply stem cell research products or you wish to expand your product line, you’ll know just how essential and lucrative this market is. We ... \| read more...	$2,995.00
Stem Cell Approaches in Neurology and Psychiatry - 25 Trendsetters for 2013 11/27/2012 \| published by: NeuroInsights, LLC ... including funding and regulatory issues Reveals promising treatment indications and pipelines Details cell therapies for Parkinson's, SCI, stroke, Alzheimer's, ALS, MS, retina and more Examines business models leveraging the promise of stem cells Sheds light ... \| read more...	$2,950.00
Plunkett's Health Care Technologies Overview 2013: A Summary Excerpted from Plunkett's Health Care Industry Almanac 2013 11/7/2012 \| published by: Plunkett Research, Ltd. ... Online Link to our 5-minute video overview of this industry Pages: 77 Statistical Tables Provided: 39 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Health Care Industry Almanac 2013, including forecasts and ... \| read more...	$199.99
Plunkett's Health Care Industry Almanac 2013: Health Care Industry Market Research, Statistics, Trends & Leading Companies 11/7/2012 \| published by: Plunkett Research, Ltd. ... Industry Glossary Buyer may register for access to search and export data at Plunkett Research Online Link to our 5-minute video overview of this industry Pages: 694 Statistical Tables Provided: 39 Companies Profiled: 468 Geographic ... \| read more...	$349.99
Plunkett's Health Care Industry Trends & Statistics 2013: A Summary Version of Plunkett's Health Care Industry Almanac 2013 11/7/2012 \| published by: Plunkett Research, Ltd. ... Plunkett Research Online Link to our 5-minute video overview of this industry Pages: 76 Statistical Tables Provided: 39 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Health Care Industry Almanac 2013, including ... \| read more...	$199.99
The Market for Stem Cell Research Products: Current and Future Opportunities 11/1/2012 \| published by: BioInformatics, LLC ... diseases are treated. Pharmaceutical and biotech companies are seeking to leverage portfolios beleaguered by high drug attrition rates and expiring patents, and the use of stem cells in the drug discovery phase, rapid developments in ... \| read more...	$3,200.00
Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017) (Neurodegenerative, cardiovascular, cancer & autoimmune, skin and infectious diseases) 10/26/2012 \| published by: MarketsandMarkets ... as next pillar or advancement in medical care. Growth of the market is very rapid especially in regulatory approvals, applications areas and rapid improvements in efficacy of treatment; it has enormous advantages over allogenic stem ... \| read more...	$4,650.00
Cancer Stem Cells Drug Pipeline Update 2012 10/16/2012 \| published by: BioSeeker Group AB ... the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today 207 companies plus partners developing 254 cancer stem ... \| read more...	$2,249.00
Biotechnology Market in India 10/1/2012 \| published by: Taiyou Research ... costs have boosted the growth of the industry. With the industry not facing much of the brunt from the global economic recession, the Indian biotechnology industry has been gathering investment and is benefitting from the ... \| read more...	$600.00
Strategies and Technologies for Target Validation 9/28/2012 \| published by: Datamonitor ... major cause of clinical-stage attrition. This report analyses the strategic and technological developments in the field. Features and benefits Understand how the differences between phenotypic and target-based approaches to drug discovery influence target validation strategies. ... \| read more...	$3,800.00
Translational Regenerative Medicine: Market Prospects 2012-2022 8/31/2012 \| published by: Visiongain ... to 2022. There you investigate the most lucrative areas in that research field, industry and market. Discover prospects for tissue-engineered products, stem cell treatments and gene therapy. We pack our study with information and analysis ... \| read more...	$2,739.00

< prev 1 2 3 4 5 next >